Chances are high these guys get munched for a lot of money. Too bad there's no ipo window or busted biotech with $100M in cash that could entice them to reverse merge :)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.